Loading data
HBIONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 86.55 m USD | 94.14 m USD | 112.25 m USD | 113.34 m USD | 118.9 m USD |
| Cost of revenue | 36.64 m USD | 39.37 m USD | 46.18 m USD | 52.52 m USD | 51.25 m USD |
| Gross profit | 49.91 m USD | 54.77 m USD | 66.07 m USD | 60.82 m USD | 67.65 m USD |
| Research and development expense | 8.83 m USD | 10.41 m USD | 11.76 m USD | 12.33 m USD | 10.8 m USD |
| Operating profit | -48.58 m USD | -6.21 m USD | 1.89 m USD | -6.93 m USD | 2.07 m USD |
| Profit before tax | -57.39 m USD | -11.67 m USD | -2.56 m USD | -9.18 m USD | -140 k USD |
| Income tax expense | -686 k USD | 740 k USD | 859 k USD | 337 k USD | 148 k USD |
| Net income (reported basis) | -56.7 m USD | -12.41 m USD | -3.42 m USD | -9.52 m USD | -288 k USD |
| Basic earnings per share | -1.28 USD/share | -0.28 USD/share | -0.08 USD/share | -0.23 USD/share | -0.01 USD/share |
| Diluted earnings per share | -1.28 USD/share | -0.28 USD/share | -0.08 USD/share | -0.23 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.